At the Annual
In a separate transaction
For further information, please contact:
CEO Jeppe Øvlesen
Tel: +45 2844 7567
Email: joo@synactpharma.com
About
© Modular Finance, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.995 SEK | +2.87% | -0.71% | -20.78% |
04-23 | Synact Pharma AB Announces Changes in Nomination Committee Ahead of the 2024 Annual General Meeting | CI |
03-20 | Sweden's SynAct Pharma Names New CEO | MT |
At the Annual
In a separate transaction
For further information, please contact:
CEO Jeppe Øvlesen
Tel: +45 2844 7567
Email: joo@synactpharma.com
About
© Modular Finance, source
1st Jan change | Capi. | |
---|---|---|
-20.78% | 26.66M | |
+45.61% | 54.63B | |
-7.01% | 39.92B | |
+37.07% | 38.82B | |
+13.09% | 26.86B | |
-11.17% | 26.22B | |
-21.55% | 18.78B | |
+25.72% | 12.21B | |
+0.58% | 12.16B | |
+25.48% | 11.94B |